Edesa Biotech Stock Price on December 12, 2024
| EDSA Stock | USD 1.80 0.02 1.12% |
Below is the normalized historical share price chart for Edesa Biotech extending back to June 21, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Edesa Biotech stands at 1.80, as last reported on the 13th of December 2024, with the highest price reaching 1.84 and the lowest price hitting 1.79 during the day.
If you're considering investing in Edesa Stock, it is important to understand the factors that can impact its price. Edesa Biotech secures Sharpe Ratio (or Efficiency) of -0.24, which denotes the company had a -0.24% return per unit of risk over the last 3 months. Edesa Biotech exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Edesa Biotech's Mean Deviation of 3.41, standard deviation of 4.87, and Variance of 23.67 to check the risk estimate we provide.
At present, Edesa Biotech's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 15.7 M, whereas Total Stockholder Equity is forecasted to decline to about 6.4 M. . At present, Edesa Biotech's Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 115.07, whereas Price Earnings Ratio is projected to grow to (95.00). Edesa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of November 2015 | 200 Day MA 4.1146 | 50 Day MA 3.0024 | Beta 0.838 |
Edesa |
Sharpe Ratio = -0.2438
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EDSA |
Estimated Market Risk
| 4.96 actual daily | 44 56% of assets are more volatile |
Expected Return
| -1.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Edesa Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Edesa Biotech by adding Edesa Biotech to a well-diversified portfolio.
Price Book 2.0161 | Enterprise Value Ebitda (1.25) | Price Sales 120.5 K | Shares Float 2.4 M | Wall Street Target Price 20.5 |
Related Headline
Iovance Biotherapeutics Headline on 12th of December 2024
Prediction This Stock Will Beat the Market in 2025 by finance.yahoo.com
It hasnt been a great year for Iovance Biotherapeutics , an innovative mid-cap biotech company. Lets look deeper into how Iovance Biotherapeutics could pull that off. It is manufactured using patients own TIL cells, which can identify and kill cancer cells.
Edesa Biotech Valuation on December 12, 2024
It is possible to determine the worth of Edesa Biotech on a given historical date. On December 12, 2024 Edesa was worth 1.79 at the beginning of the trading date compared to the closed value of 1.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Edesa Biotech stock. Still, in general, we apply an absolute valuation method to find Edesa Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Edesa Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Edesa Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 1.77 | 1.90 | 1.77 | 1.78 | 15,353 | |
12/12/2024 | 1.79 | 1.84 | 1.79 | 1.80 | 5,860 |
| Backtest Edesa Biotech | | | Edesa Biotech History | | | Edesa Biotech Valuation | Previous |
Edesa Biotech Trading Date Momentum on December 12, 2024
| On December 12 2024 Edesa Biotech was traded for 1.80 at the closing time. The top price for the day was 1.84 and the lowest listed price was 1.79 . The trading volume for the day was 5.9 K. The trading history from December 12, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.56% . |
Edesa Biotech Fundamentals Correlations and Trends
By evaluating Edesa Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Edesa Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Edesa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Edesa Biotech Stock history
Edesa Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Edesa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Edesa Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Edesa Biotech stock prices may prove useful in developing a viable investing in Edesa Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.3 M | 3.5 M | |
| Net Loss | -15.8 M | -15 M |
Edesa Biotech Quarterly Net Working Capital |
|
Edesa Biotech Stock Technical Analysis
Edesa Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Edesa Biotech Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Edesa Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Edesa Biotech December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Edesa Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Edesa Biotech shares will generate the highest return on investment. By undertsting and applying Edesa Biotech stock market strength indicators, traders can identify Edesa Biotech entry and exit signals to maximize returns
Edesa Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Edesa Biotech's price direction in advance. Along with the technical and fundamental analysis of Edesa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Edesa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.37) | |||
| Total Risk Alpha | (1.90) | |||
| Treynor Ratio | (0.82) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Edesa Stock analysis
When running Edesa Biotech's price analysis, check to measure Edesa Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edesa Biotech is operating at the current time. Most of Edesa Biotech's value examination focuses on studying past and present price action to predict the probability of Edesa Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edesa Biotech's price. Additionally, you may evaluate how the addition of Edesa Biotech to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |